JPWO2022266415A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022266415A5
JPWO2022266415A5 JP2023577658A JP2023577658A JPWO2022266415A5 JP WO2022266415 A5 JPWO2022266415 A5 JP WO2022266415A5 JP 2023577658 A JP2023577658 A JP 2023577658A JP 2023577658 A JP2023577658 A JP 2023577658A JP WO2022266415 A5 JPWO2022266415 A5 JP WO2022266415A5
Authority
JP
Japan
Prior art keywords
modified oligonucleotide
modified
oligomeric compound
seq
exoregion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023577658A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523363A (ja
JP2024523363A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/033936 external-priority patent/WO2022266415A1/en
Publication of JP2024523363A publication Critical patent/JP2024523363A/ja
Publication of JPWO2022266415A5 publication Critical patent/JPWO2022266415A5/ja
Publication of JP2024523363A5 publication Critical patent/JP2024523363A5/ja
Pending legal-status Critical Current

Links

JP2023577658A 2021-06-18 2022-06-17 Ｉｆｎａｒ１の発現を低減するための化合物及び方法 Pending JP2024523363A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163212476P 2021-06-18 2021-06-18
US63/212,476 2021-06-18
PCT/US2022/033936 WO2022266415A1 (en) 2021-06-18 2022-06-17 Compounds and methods for reducing ifnar1 expression

Publications (3)

Publication Number Publication Date
JP2024523363A JP2024523363A (ja) 2024-06-28
JPWO2022266415A5 true JPWO2022266415A5 (https=) 2025-06-25
JP2024523363A5 JP2024523363A5 (https=) 2025-06-25

Family

ID=84527458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023577658A Pending JP2024523363A (ja) 2021-06-18 2022-06-17 Ｉｆｎａｒ１の発現を低減するための化合物及び方法

Country Status (4)

Country Link
US (1) US20250188476A1 (https=)
EP (1) EP4355338A4 (https=)
JP (1) JP2024523363A (https=)
WO (1) WO2022266415A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240023602A (ko) 2021-06-18 2024-02-22 아이오니스 파마수티컬즈, 인코포레이티드 Ifnar1 발현을 감소시키기 위한 화합물 및 방법
KR20260005258A (ko) * 2023-04-21 2026-01-09 세카나 파머씨티컬스 지엠비에이치 엔 씨오. 케이지 Nrp1 특이적 안티센스 올리고뉴클레오티드 및 질병 예방 및/또는 치료에 있어서의 그 용도
EP4724582A1 (en) * 2023-06-07 2026-04-15 Massachusetts Institute of Technology Rna-loaded lipid nanoparticles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0807172A1 (en) * 1995-01-30 1997-11-19 HYBRIDON, Inc. Human immunodeficiency virus transcription inhibitors and methods of their use
WO2012068636A1 (en) * 2010-11-26 2012-05-31 The University Of Melbourne Methods and compositions comprising antagonists of type 1 interferon-mediated signalling for reducing a neuroinflammatory response in the central nervous system
AU2014274730A1 (en) * 2013-06-07 2016-01-21 Rana Therapeutics, Inc. Compositions and methods for modulating FOXP3 expression
US20200345756A1 (en) * 2017-10-10 2020-11-05 University Of Virginia Patent Foundation Compositions and methods for treating age-related macular degeneration and geographic atrophy
EP3713955A4 (en) * 2018-09-18 2022-03-09 I-Mab Biopharma (Hangzhou) Co., Ltd. ANTI-IFNAR1 ANTIBODIES FOR THE TREATMENT OF AUTOIMMUNE DISEASES
US20220064636A1 (en) * 2018-10-05 2022-03-03 Ionis Pharmaceuticals, Inc. Modified oligomeric compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP7554488B2 (ja) 血液脳関門通過型ヘテロ２本鎖核酸
JP2020193199A5 (https=)
WO2023022229A1 (ja) モルホリノ核酸を含む修飾ヘテロ核酸
CA3241870A1 (en) Splice switcher antisense oligonucleotides with modified backbone chemistries
CN114929876A (zh) Atn1的反义寡核苷酸
JP7737667B2 (ja) 核酸複合体
WO2021187392A1 (ja) モルホリノ核酸を含むヘテロ核酸
JPWO2022266415A5 (https=)
JPWO2020160163A5 (https=)
JPWO2020247419A5 (https=)
JPWO2022246251A5 (https=)
JPWO2023064707A5 (https=)
WO2022211129A1 (ja) Ａｔｎ１のアンチセンスオリゴヌクレオチド誘導体
JPWO2022159712A5 (https=)
JPWO2020190740A5 (https=)
JPWO2020172559A5 (https=)
JPWO2022032060A5 (https=)
JPWO2021258011A5 (https=)
JPWO2021252799A5 (https=)
RU2025125439A (ru) Лель-селективные соединения и способы модуляции экспрессии хантингтина
JPWO2020055917A5 (https=)
JPWO2022204430A5 (https=)
JPWO2022066956A5 (https=)
JPWO2022006134A5 (https=)
JPWO2022072787A5 (https=)